Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,286 | -27,582 | -20,915 | -16,716 | -5,475 |
| Depreciation Amortization | 345 | 3,791 | 3,428 | 2,502 | 1,231 |
| Accounts receivable | -2,314 | -1,032 | -4,075 | -1,587 | -2,282 |
| Other Working Capital | -4,611 | 9,801 | 9,334 | 9,660 | -6,215 |
| Other Operating Activity | 3,037 | 4,737 | 7,030 | 2,823 | 2,907 |
| Operating Cash Flow | $-5,829 | $-10,285 | $-5,198 | $-3,318 | $-9,834 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 58,271 | 20,359 | 15,359 | 7,512 |
| PPE Investments | -229 | -1,406 | -958 | -614 | -333 |
| Purchase Of Investment | -16,000 | -37,835 | -37,835 | -37,835 | -37,835 |
| Other Investing Activity | -28 | -109 | -81 | -54 | -28 |
| Investing Cash Flow | $-16,257 | $18,921 | $-18,515 | $-23,144 | $-30,684 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -34,122 | -30,076 | N/A | -4,086 |
| Common Stock Issued | N/A | 46,200 | 46,200 | 46,200 | 46,200 |
| Other Financing Activity | 0 | 0 | 0 | -4,086 | 0 |
| Financing Cash Flow | $N/A | $12,078 | $16,124 | $42,114 | $42,114 |
| Exchange Rate Effect | -11 | 6 | -34 | -35 | -31 |
| Beginning Cash Position | 38,985 | 18,265 | 18,265 | 18,265 | 18,265 |
| End Cash Position | 16,888 | 38,985 | 10,642 | 33,882 | 19,830 |
| Net Cash Flow | $-22,097 | $20,720 | $-7,623 | $15,617 | $1,565 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,829 | -10,285 | -5,198 | -3,318 | -9,834 |
| Capital Expenditure | -229 | -1,459 | -1,011 | -667 | -386 |
| Free Cash Flow | -6,058 | -11,744 | -6,209 | -3,985 | -10,220 |